Randomized open controlled clinical trial of nagaradi churna on kaphaja pandu w s r to anemia
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 110
- Locations
- 1
- Primary Endpoint
- Scales of following symptoms
Study Overview
Brief Summary
As iron deficiency anemia is the most common type of the anemia
worldwide. In conventional medicine various forms of treatment are used. There are some adverse effects of allopathic treatment. As the anemia is very common prevalent disease in the society, so to get better alternative, an ayurvedic herbo-mineral medicine, Nagaradi Churna will be subjected to a clinical trial in the anemic patients.
The present study was carried out to carry the efficiency of an
Ayurveda herbomineral compound “NAGARADI CHURNAâ€
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 16.00 Year(s) to 60.00 Year(s) (—)
Inclusion Criteria
- •1.Gender-Patients of any gender will be included.
- •2.Age-16 yrs to 60 yrs 3.Patients those having Lakshanas of kaphaja Pandu.
- •4.Hb% ranges above 7gm/dL to 10gm/dL.
- •5.Patient who shows Panduta,Guruta,Tandra, shithilata, Alasya ,Aruchi, shwas will be included for study.
Exclusion Criteria
- •1.Pregnant women, Lactating mothers.
- •2.Anemia associated with other known history of diseases like Nephrotic Syndrome, Liver Cirrhosis, Ascites, Congestive Cardiac Failure, Acute Coronary Syndromes, Leprosy, Auto- Immune Disorders etc.
- •3.Patients having known history of Chronic Blood loss conditions such as Malena, Haemetemesis, Haemorrhagic Piles, Menorrhagia, Metrorrhagia, etc.
Outcomes
Primary Outcomes
Scales of following symptoms
Time Frame: 2 weeks
1)Panduta
Time Frame: 2 weeks
3)Tandra
Time Frame: 2 weeks
5)Shwas
Time Frame: 2 weeks
6)Aruchi
Time Frame: 2 weeks
7)Shithilata
Time Frame: 2 weeks
2)Guruta
Time Frame: 2 weeks
4)Alasya
Time Frame: 2 weeks
Secondary Outcomes
- Increase hemoglobin(90 days)